Year archive

Isofol Medical — 2021 filings

All 10 regulatory filings released by Isofol Medical (ISOFOL) in 2021, sourced directly from the official regulator.

10 Filings

2021 Period

2021 filings (10)

Filing	Released	Lang
Isofol Medical AB (publ) will not reach 300 PFS events in the AGENT study with current censoring rules based on FDA decision Regulatory Filings	2021-12-03	English
Isofol Medical AB (publ) når inte 300 PFS-händelser i AGENT-studien med nuvarande censureringsregler baserat på FDA-beslut Regulatory Filings	2021-12-03	Swedish
Isofol Medical AB (publ) receives FDA Fast Track Designation for arfolitixorin in advanced colorectal cancer (mCRC) Regulatory Filings	2021-11-23	English
Isofol Medical AB (publ) beviljas Fast Track Designation av FDA för arfolitixorin för behandling av avancerad kolorektal cancer Regulatory Filings	2021-11-23	Swedish
Isofol har utsett valberedningen inför årsstämman 2022 Board/Management Information	2021-11-19	Swedish
Isofol appoints nomination committee ahead of the Annual General Meeting 2022 Board/Management Information	2021-11-19	English
Regulatory Filings 2021 Regulatory Filings	2021-11-11	English
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-11	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-11	English
Handeln i Isofols aktier inleds idag på Nasdaq Stockholm Capital/Financing Update	2021-10-21	Swedish